Role of endogenous cholecystokinin on growth of human pancreatic cancer

International Journal of Oncology

Volumn 38, Issue 3, 2011, Pages 593-601

  Matters, Gail L ^a   McGovern, Christopher ^a   Harms, John F ^b   Markovic, Kevin ^b   Anson, Krystal ^a   Jayakumar, Calpurnia ^a   Martenis, Melissa ^a   Awad, Christina ^b   Smith, Jill P ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b MESSIAH COLLEGE   (United States)

Author keywords

Cholecystokinin; Gastrin; Immunocytochemistry; Pancreatic cancer; RNAi; Tumor growth

Indexed keywords

CHOLECYSTOKININ; CHOLECYSTOKININ A RECEPTOR; CHOLECYSTOKININ B RECEPTOR; GASTRIN; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER GROWTH; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN ANALYSIS; RADIOIMMUNOASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOCARCINOMA; ANIMALS; ANTIBODIES, NEUTRALIZING; AUTOCRINE COMMUNICATION; CELL LINE, TUMOR; CELL PROLIFERATION; CHOLECYSTOKININ; GASTRINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICE; MICE, NUDE; PANCREATIC NEOPLASMS; RNA, MESSENGER; RNA, SMALL INTERFERING; TISSUE DISTRIBUTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79952015540     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2010.886     Document Type: Article

References (28)

1. Pai SI, Lin YY, Macaes B, Meneshian A, Hung CF and Wu TC: Prospects of RNA interference therapy for cancer. Gene Ther 13: 464-477, 2006.
2. Smith JP, Kramer ST and Solomon TE: CCK stimulates growth of six human pancreatic cancer cell lines in serum-free medium. Regul Pept 32: 341-349, 1991.
3. Smith JP, Fantaskey AP, Liu G and Zagon IS: Identification of gastrin as a growth peptide in human pancreatic cancer. Am J Physiol 268: R135-R141, 1995.
4. Smith JP, Liu G, Soundararajan V, McLaughlin PJ and Zagon IS: Identification and characterization of CCK-B/gastrin receptors in human pancreatic cancer cell lines. Am J Physiol 266: R277-R283, 1994.
5. Smith JP and Zagon IS: Cholecystokinin receptors and human pancreatic adenocarcinomas. Int J Pancreatol 16: 243-246, 1994. (Pubitemid 24337872)
6. Smith JP, Verderame MF, McLaughlin P, Martenis M, Ballard E and Zagon IS: Characterization of the CCK-C (cancer) receptor in human pancreatic cancer. Int J Mol Med 10: 689-694, 2002.
7. Smith JP, Shih A, Wu Y, McLaughlin PJ and Zagon IS: Gastrin regulates growth of human pancreatic cancer in a tonic and autocrine fashion. Am J Physiol 270: R1078-R1084, 1996.
8. Bardram L, Hilsted L and Rehfeld JF: Progastrin expression in mammalian pancreas. Proc Natl Acad Sci USA 87: 298-302, 1990.
9. Smith JP, Hamory MW, Verderame MF and Zagon IS: Quantitative analysis of gastrin mRNA and peptide in normal and cancerous human pancreas. Int J Mol Med 2: 309-315, 1998.
10. Brand SJ and Fuller PJ: Differential gastrin gene expression in rat gastrointestinal tract and pancreas during neonatal development. J Biol Chem 263: 5341-5347, 1988.
11. Seretis EC, Gavriil AN, Golematis VC and Voloudakis-Baltatzis IE: Immunoelectron study of pancreatic carcinomas using antibodies to gastrointestinal hormones. Ultrastruct Pathol 31: 303-314, 2007. (Pubitemid 47359958)
12. Grabowska AM and Watson SA: Role of gastrin peptides in carcinogenesis. Cancer Lett 257: 1-15, 2007. (Pubitemid 47495970)
13. Harris JC, Gilliam AD, McKenzie AJ, Evans SA, Grabowska AM, Clarke PA, McWilliams DF and Watson SA: The biological and therapeutic importance of gastrin gene expression in pancreatic adenocarcinomas. Cancer Res 64: 5624-5631, 2004. (Pubitemid 39095558)
14. Matters GL, Harms JF, McGovern CO, Jayakumar C, Crepin K, Smith ZP, Nelson MC, Stock H, Fenn CW, Kaiser J, Kester M and Smith JP: Growth of human pancreatic cancer is inhibited by down-regulation of gastrin gene expression. Pancreas 38: e151-e161, 2009.
15. Smith JP, Solomon TE, Bagheri S and Kramer S: Cholecystokinin stimulates growth of human pancreatic adenocarcinoma SW-1990. Dig Dis Sci 35: 1377-1384, 1990. (Pubitemid 20377968)
16. Goetze JP, Nielsen FC, Burcharth F and Rehfeld JF: Closing the gastrin loop in pancreatic carcinoma: coexpression of gastrin and its receptor in solid human pancreatic adenocarcinoma. Cancer 88: 2487-2494, 2000. (Pubitemid 30331954)
17. Tamiolakis D, Venizelos I, Simopoulos C, Lambropoulou M, Kotini A, Jivannakis T, Alexiadis G, Boglou P and Papadopoulos N: Does neoplastic cholecystokinin expression reflect the embryonal pattern of the protein? A study in human pancreas. Acta Medica (Hradec Kralove) 47: 101-105, 2004.
18. Paloheimo LI and Rehfeld JF: A processing-independent assay for human procholecystokinin and its products. Clin Chim Acta 229: 49-65, 1994. (Pubitemid 24269172)
19. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408, 2001. (Pubitemid 34164012)
20. Weinberg DS, Ruggeri B, Barber MT, Biswas S, Miknyocki S and Waldman SA: Cholecystokinin A and B receptors are differentially expressed in normal pancreas and pancreatic adenocarcinoma. J Clin Invest 100: 597-603, 1997. (Pubitemid 27340507)
21. Gardner JD, Walker MD, Martinez J, Priestly GP, Natarajan S and Bodanszky M: The importance of the amino acid in position 27 of cholecystokinin in determining its biological activity on pancreatic acini. Biochim Biophys Acta 630: 323-329, 1980. (Pubitemid 10027803)
22. Smith JP, Rickabaugh CA, McLaughlin PJ and Zagon IS: Cholecystokinin receptors and PANC-1 human pancreatic cancer cells. Am J Physiol 265: G149-G155, 1993. (Pubitemid 23223101)
23. Watson SA, Clarke PA, Smith AM, Varro A, Michaeli D, Grimes S, Caplin M and Hardcastle JD: Expression of CCKB/gastrin receptor isoforms in gastro-intestinal tumour cells. Int J Cancer 77: 572-577, 1998. (Pubitemid 28340906)
24. Amer MS: Studies with cholecystokinin. II. Cholecystokinetic potency of porcine gastrins I and II and related peptides in three systems. Endocrinology 84: 1277-1281, 1969.
25. Duxbury MS, Ito H, Zinner MJ, Ashley SW and Whang EE: EphA2: a determinant of malignant cellular behavior and a potential therapeutic target in pancreatic adenocarcinoma. Oncogene 23: 1448-1456. 2004. (Pubitemid 38406840)
26. Schubert KM, Scheid MP and Duronio V: Ceramide inhibits protein kinase B/Akt by promoting dephosphorylation of serine 473. J Biol Chem 275: 13330-13335, 2000. (Pubitemid 30257390)
27. Wei SH, Dong K, Lin F, Wang X, Li B, Shen JJ, Zhang Q, Wang R and Zhang HZ: Inducing apoptosis and enhancing chemosensitivity to gemcitabine via RNA interference targeting Mcl-1 gene in pancreatic carcinoma cell. Cancer Chemother Pharmacol 62: 1055-1064, 2008.
28. Carrillo J, Garcia-Aragoncillo E, Azorin D, Agra N, Sastre A, Gonzalez-Mediero I, Garcia-Miguel P, Pestana A, Gallego S, Segura D and Alonso J: Cholecystokinin down-regulation by RNA interference impairs Ewing tumor growth. Clin Cancer Res 13: 2429-2440, 2007. (Pubitemid 46698594)